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التوكوتراينول املشتق من زيت النخيل مينع ضرر اإلجهاد التأكسدي يف 
اجلرذان املصابة بداء السكري
فاطمة علي معتوق, �صيتي بلقي�س بودين, ز�ريانتي عبد�حلميد, مارياتي عبد �لرحمن, نا�رش �لوهيبي, جمال �لدين حممد
abstract: Objectives: This study was carried out to determine the effects of tocotrienol-rich fraction (TRF) 
(200 mg/Kg) on biomarkers of oxidative stress on erythrocyte membranes and leukocyte deoxyribonucleic acid 
(DNA) damage in streptozotocin (STZ)-induced diabetic rats. Methods: Male rats (n = 40) were divided randomly 
into four groups of 10: a normal group; a normal group with TRF; a diabetic group, and a diabetic group with 
TRF. Following four weeks of treatment, fasting blood glucose (FBG) levels, oxidative stress markers and the 
antioxidant status of the erythrocytes were measured. Results: FBG levels for the STZ-induced diabetic rats were 
significantly increased (P <0.001) when compared to the normal group and erythrocyte malondialdehyde levels 
were also significantly higher (P <0.0001) in this group. Decreased levels of reduced glutathione and increased levels 
of oxidised glutathione  (P <0.001) were observed in STZ-induced diabetic rats when compared to the control group 
and diabetic group with TRF. The results of the superoxide dismutase and glutathione peroxidase activities were 
significantly lower in the STZ-induced diabetic rats than in the normal group (P <0.001). The levels of DNA damage, 
measured by the tail length and tail moment of the leukocyte, were significantly higher in STZ-induced diabetic 
(P <0.0001). TRF supplementation managed to normalise the level of DNA damage in diabetic rats treated with TRF. 
Conclusion: Daily supplementation with 200 mg/Kg of TRF for four weeks was found to reduce levels of oxidative 
stress markers by inhibiting lipid peroxidation and increasing the levels of antioxidant status in a prevention trial 
for STZ-induced diabetic rats.
Keywords: Antioxidants; Diabetes Mellitus; Oxidative Stress; Tocotrienols.
امللخ�ص: الهدف: تهدف هذه �لدر��صة �يل حتديد تاأثري فعالية �لتوكوتر�ينول )200 ملجم/كجم( على �ملوؤ�رش�ت �حليوية لالإجهاد �لتاأك�صدي فى �أغ�صية 
كريات �لدم �حلمر�ء وجزيئة �حلم�س �لنووي �لريبي منقو�س �الأك�صجي )DNA( يف �جلرذ�ن �مل�صابة بد�ء �ل�صكري �ملحدث بو��صطة �ل�صرتيبتوزوتو�صي. 
الطريقة: مت تق�صيم 40 جرذ ذكر ع�صو�ئيا �يل �أربع جمموعات مت�صاوية كالتايل: جمموعة طبيعية وجمموعة طبيعية �أعطت توكوتر�ينول وجمموعة م�صابة 
بد�ء �ل�صكري وجمموعة م�صابة بد�ء �ل�صكري �أعطت توكوتر�ينول. بعد فرتة �أربع ��صابيع من �لعالج مت قيا�س م�صتوى �جللوكوز يف �لدم وم�صتويات �ملوؤ�رش�ت 
معنويا  �زدياد�  �ل�صكري  بد�ء  �مل�صابة  �جلرذ�ن  جمموعة  �أظهرت  النتائج:  �حلمر�ء.  �لدم  لكريات  �الأك�صدة  م�صاد�ت  وحالة  �لتاأك�صدي  لالأجهاد  �حليوية 
�ح�صائيا يف م�صتوى �جللوكوز وم�صتوى �ملالونديليهايد مقارنة باملجموعة �لطبيعية. كما �أظهرت �لنتائج باأن هناك �نخفا�صا يف م�صتوى �حلالة �ملختزلة 
للجلوتاثيون وباملقابل �زدياد يف م�صتوى �حلالة �ملوؤك�صدة للجلوتاثيون يف �ملجموعة �مل�صابة بد�ء �ل�صكري مقارنة باملجموعة �لطبيعية. من جهة �أخرى 
كان هناك �نخفا�س معنوي �ح�صائي يف م�صتوى ن�صاط �نزميي �ل�صوبر �ك�صيد دي�صميوتيز و �جللتاثيون بريوك�صيديز يف �ملجموعة �مل�صابة بد�ء �ل�صكري. 
مقارنة  �ل�صكري  بد�ء  �مل�صابة  �ملجموعة  يف  �لبي�صاء  �لدم  لكريات   )DNA( جزيئة  يف  �ل�رشر  م�صتوى  يف  �ح�صائي  معنوي  �رتفاع  هناك  كان  �أي�صا 
باملجموعة �لطبيعية. لقد بينت �لنتائج باأن �لعالج بالتوكوتر�ينول كان فعاال يف معادلة �صمية و�رشر جزيئة )DNA( يف جمموعة �جلرذ�ن �مل�صابة بد�ء 
�ل�صكري. اخلال�سة: وجد �أن تناول 200 ملجم / كجم يوميا ملدة �أربعة ��صابيع فعال يف تخفي�س م�صتويات �ملوؤ�رش�ت �حليوية لالإجهاد �لتاأك�صدي وذلك عن 
طريق تثبيط تاأك�صد �لدهون وزيادة يف م�صتويات م�صاد�ت �الأك�صدة يف �جلرذ�ن �مل�صابة بد�ء �ل�صكري.
مفتاح الكلمات: م�صاد�ت �الأك�صدة؛ مر�س �ل�صكري؛ �الإجهاد �لتاأك�صدي؛ �لتوكوتر�ينول.
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Advances in Knowledge
- The antioxidant potential of tocotrienols has been a focus of scientific interest in recent years. Recent findings have shown that tocotrienols 
are responsible for the majority of the activity of vitamin E. This study shows that a tocotrienol-rich fraction (TRF) from palm oil at 200 
mg/Kg of body weight for four weeks provides sufficient antioxidant activity to reduce oxidative stress, by inhibiting lipid peroxidation 
and reducing levels of deribonucleic acid (DNA) damage, as well as increasing the status of the antioxidant system in a prevention trial 
for diabetic rats.
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According to the World Health Organization (WHO), a total of 171 million people in all age groups worldwide 
(2.8% of the world’s population) have diabetes; this 
number is expected to rise to 366 million (4.4% 
of the world’s population) by 2030.1 A balance 
between the rate of free radical generation and 
the rate of radical elimination is important so that 
cellular radical generation is not harmful.2 However, 
if there is a significant increase in radical generation 
or a decrease in radical elimination of the cells, this 
balance is disrupted, resulting in the formation of 
oxidative stress.3 Free radicals and oxidative stress 
are among the factors involved in the pathogenesis 
of diabetes; in particular, they appear to play a major 
role in the development of chronic complications 
from diabetes.4
Vitamin E is widely accepted as the first line of 
defense against lipid peroxidation, protecting the 
polyunsaturated fatty acids in the cell membranes 
through its free radical-quenching activity in the 
biomembranes in the early stages of the free radical 
attack.5 Palm oil contains a larger concentration 
of tocotrienols (70%) than any other natural 
source, except annatto (100%).6 Tocotrienols 
and tocopherols act as potent antioxidants, 
serving to protect the cellular membranes 
from free radical-catalysed lipid peroxidation.7 
A number of health-related biological properties of 
tocotrienols have been identified, including anti-
cancer, anti-cholesterolemic, antihypertensive, 
antioxidant, immunomodulatory and neuro-
protective properties.6
Tocotrienol-rich fraction (TRF) has unique 
biological properties that make it a potential 
neuroprotective dietary factor. In addition to 
its antioxidant activity, TRF at micromolar 
concentrations displays cholesterol-lowering 
activities in cells, animal models and some, but 
not all, human subjects by means of the inhibition 
of the activity of the rate-limiting enzyme in 
cholesterol biosynthesis, 3-hydroxy-3-methylgluta- 
ryl coenzyme A reductase.8 Furthermore, TRF at 
lower concentrations (~10 nmol/L) modulates 
signalling pathways involved in neuronal cell 
death in cell culture experiments.8 Currently, 
TRF is addressed as an anti-apoptotic and anti-
inflammatory agent, and emerging findings suggest 
a role for nuclear factor kappa-B cells (NF-κB) 
as a mediator of the effects of dietary factors on 
neuronal plasticity.9
Our previous study showed that the TRF of 
palm oil (200 mg/Kg of body weight) has some 
protective effects as it reduces lipid peroxidation 
and protein oxidation, and prevents the physical 
and morphological alterations of erythrocytes 
after four weeks.10 Another study reported that 
the supplementation of TRF reduced oxidative 
stress and blood glucose levels and had protective 
effects on diabetes-induced pancreatic damage in 
diabetic rats.11 The purpose of this study was to 
investigate the effects of TRF on oxidative stress and 
antioxidant status on erythrocytes in streptozotocin 
(STZ)-induced diabetic rats.
Methods
For this study, male Sprague-Dawley rats were 
provided by the Laboratory Animal Resources 
Unit, Faculty of Medicine, Universiti Kebangsaan 
Malaysia, Kuala Lumpur. The animals were 8–10 
weeks old and weighed 200–250 g. During the study 
period, the rats had unrestricted access to food and 
tap water with a standard diet containing 22% crude 
protein, 5% crude fibre, 3% fat, 13% moisture, 8% 
ash, 0.85–1.2% calcium, 0.6–1% phosphorus and 
49% nitrogen-free extract in the form of mouse 
pellet 702-P (Gold Coin Holdings, Kuala Lumpur, 
Malaysia). They were housed in pairs in plastic 
cages with wood chips for bedding (changed weekly 
for the normal groups and daily for the diabetic 
groups). The animals were acclimatised to standard 
laboratory conditions, with a temperature of 25 °C 
with standard light-darkness cycles of 12 hours for 
one week before experimentation. The study was 
approved by the Universiti Kebangsaan Malaysia 
Animal Ethics Committee.
The experiment was designed with 40 rats, 
divided randomly into four groups of 10 rats: a 
normal group; a normal group supplemented 
Application to Patient Care
- In terms of using tocotrienols for antioxidant agent activity in diabetic humans, the finding of this study suggests that TRF at 200 mg/Kg 
for four weeks may play an important role in reducing the complications of oxidative stress-mediated diabetes mellitus. 
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with TRF; a diabetic group, and a diabetic group 
supplemented with TRF. Initially, all experimental 
groups had similar body weights (200–250 g). At 
the end of the study period, both diabetic groups 
(STZ-induced diabetic rats and diabetic rats with 
TRF) showed a significant loss of body weight 
(average weight 190 g) when compared to the 
normal groups (average weight 319 g). Diabetes 
was induced after an overnight fast by a single 
intravenous injection of STZ via the tail vein (45 mg/
Kg of body weight), which was freshly dissolved in 
a normal saline solution (9 g/L of sodium chloride). 
Three days later, blood was collected via the tail vein 
and the glucose concentration was measured by a 
strip-operated blood glucose sensor (Companion 2, 
Medisense Ltd., Birmingham, UK). Rats with blood 
glucose levels of >7.0 mmol/L were included in the 
study.
TRF was obtained from the Sime Darby 
Group (Kuala Lumpur, Malaysia) as follows: 
α-tocopherol at 171.1 mg/g, α-tocotrienol at 190.4 
mg/g, β-tocotrienol at 36.0 mg/g, γ-tocotrienol at 
211.2 mg/g and δ-tocotrienol at 150 mg/g. It was 
administered orally at a dose of 200 mg/Kg of body 
weight per day throughout the four-week feeding 
period, and supplementation was begun the same 
day. After four weeks of supplementation, all the 
rats underwent overnight fasting and were then 
euthanised by a cardiac puncture while under deep 
anaesthesia with diethyl ether.
The biochemical investigation commenced 
while the rats were under deep anaesthesia. A blood 
sample was taken from each of the rats via a cardiac 
puncture using a 21 gauge needle with a 10 ml 
syringe. Samples were then transferred into tubes 
containing a sodium fluoride plastic tube (fluoride 
oxalate tube, #X2230, Teklab Ltd., UK) for fasting 
blood glucose (FBG) analysis and ethylene diamine 
tetra acetic acid (EDTA) tubes (BD Vacutainer® 
Plus Plastic K2EDTA Tube #368589, Becton, 
Dickinson and Company, Franklin Lakes, New 
Jersey, USA) and kept on ice. Plasma glucose levels 
were analysed on the same day using enzymatic 
glucose-oxidase kits (Glucose Oxidase Reagent, 
# TR15103, Fisher Scientific Ltd., Loughborough, 
UK). Erythrocyte pellets were separated from the 
plasma and the leukocyte layer by centrifugation 
at 4,000 rpm for 10 mins at 4 °C. The supernatant 
plasma was pipetted into 1.5 ml Eppendorf tubes 
(Eppendorf AG, Hamburg, Germany) and frozen 
at -80 °C until use. After the removal of the buffy 
coat, the erythrocyte pellets were prepared by being 
washed three times with a cold (4 °C) normal saline 
(9%) solution. These pellets were then stored at 
-80 °C for biochemical analyses. The amount of 
blood taken from each rat varied from 6–10 ml. 
Erythrocyte malondialdehyde (MDA) samples 
were measured using the high performance liquid 
chromatography (HPLC) method with some 
modifications as described by Pilz et al., based on 
the derivation with 2, 4-dinitrophenylhydrazine 
(DNPH).12 The total MDA was prepared from the 
erythrocytes by perchloric acid deproteinisation 
whereas an alkaline hydrolysation step for 30 
mins at 60 °C was introduced prior to protein 
precipitation for the determination of the total (free 
and bound) MDA. The standard and samples were 
processed under the same conditions as described 
in this section. 
The MDA standard was prepared by dissolving 
25 µl of 1,1, 3,3-tetraethoxypropane (TEP) in 100 ml 
of 1% sulfuric acid to give a 1 mM stock solution and 
was kept at 4 °C overnight. The working standard 
was prepared by the hydrolysis of the 1 ml of TEP 
stock solution in 50 ml of distilled water (dH2O) 
and incubated for two hours at room temperature.13 
The concentration of 1, 2, 4, 6, 8, and 10 µmol was 
prepared from the working standard to get the 
standard curve for the estimation of total MDA. 
A solution of 200 µl of sodium hydroxide 
(NaOH) of 1.3 M was added to the 50 µl standard or 
sample. For the protein-bound alkaline hydrolysis 
step, the mixture was incubated in a 60 °C water 
bath for 30 mins and then cooled in ice for five 
mins. The hydrolysis samples were acidified with 
100 µl of 35% (volume/volume [v/v]) perchloric 
acid. After centrifugation at 1,000 g for 10 mins, 300 
µl of the supernatant were mixed with 12.5 µl of the 
DNPH solution and incubated in the dark at room 
temperature for 30 mins. Finally, 40 µl was injected 
into the HPLC system.
Analytical HPLC separations were performed 
with a 655A-12 liquid chromatography instrument 
(SCL-10AVP system controller, Shimadzu Scientific 
Instruments, Kyoto, Japan) equipped with an auto 
injector (655A-40) and a variable-wavelength 
ultraviolet (UV) detector (655A) operated at 310 
nm on a 125 × 3 mm Nucleosil C18 column of 5 µm 
particle size on reversed-phase with an integrated 
precolumn (SepServ HPCL, Separation Service 
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Berlin Ohg, Berlin, Germany). The column was kept 
at 30 °C in a column oven with a mobile phase. The 
HPLC mobile phase was prepared by mixing 380 
ml acetonitrile with 620 ml of dH2O acidified with 
0.2% (v/v) acetic acid and degassed under reduced 
pressure with a flow-rate of 1 ml/min.
Superoxide dismutase (SOD) activity was 
determined according to Fridovich and Beyer’s 
method, based on the inhibition or reduction of 
nitroblue tetrazolium (NBT).14 A reaction mixture 
of a substrate solution containing L-methionine 
(30 mg/ml), tritone X-100 (1%) and NBT (1.14 mg/
ml) was added in a phosphate buffer saline (PBS) 
solution (pH 7.8). Lyses erythrocytes (20 μl) were 
added to 0.1 ml of cold dH2O and were kept at 
4 °C for 15 mins. The mixture (1 ml) was added 
to 20 μl of lyses erythrocyte or a PBS solution 
(8 g of sodium chloride [NaCl], 0.2 g of potassium 
chloride, 1.44 g of disodium hydrogen phosphate 
and 0.24 g of monopotassium phosphate) (control), 
and 10 μl of riboflavin was then added. The samples 
were incubated for seven mins. The absorbance 
of the mixture at 560 nm was determined using a 
spectrophotometer UV-160A (Shimadzu Scientific 
Instruments). The enzyme activities were calculated 
in U/g haemoglobin (Hb).
Glutathione peroxidase (GPx) activity was 
determined according to the Lawrence method, 
based on the principle that GPx catalyses the 
oxidation of glutaredoxin (GRx) and nicotinamide 
adenine dinucleotide phosphate (NADPH).15 The 
oxidised glutathione was immediately converted 
to the reduced form with a concomitant oxidation, 
NADPH to NADP+. A 100 μl sample of lysed 
erythrocyte and 0.8 ml of a buffered solution (1 
mM of sodium azide, 1 mM of EDTA, 0.2 mM 
of NADPH, 50 units of GRx1 mM of GSH and 
50 mM of PBS; pH 7) were incubated at room 
temperature for 5 mins, then 100 μl (0.25 mM) of 
hydrogen peroxide was added. The absorbance of 
the mixture at 340 nm was determined using the 
Shimadzu Scientific Instruments spectrophoto- 
meter. Activities of enzymes were calculated in 
U/g Hb. A commercial glutathione detection kit 
(BioVision, Inc., Milpitas, California, USA) was 
used to measure GSH, GSSG and total glutathione. 
The readings for samples and the standard were 
determined using a fluorescence plate reader 
equipped with an excitation wavelength/emission 
wavelength (Ex/Em) of 340/420 nm (SkanIt 
Software, Thermo Fisher Scientific Inc.).
The concentration of vitamin E in the rat 
erythrocyte samples was measured by the HPLC 
method with some modification of the procedures 
described by Brandt et al.16 Briefly, α-tocopherol 
and α-tocopheryl-acetate (the internal standard) in 
the samples were extracted into hexane. The hexane 
extract was dried under nitrogen and dissolved in 
the mobile phase for injection into the HPLC for 
separation with detection by UV. The mobile phase 
used was composed of methanol and toluene of 
HPLC grade (BDH Merck Ltd., Poole, UK) in the 
ratio of 80:20.
A stock standard of 10 mmol/L of α-tocopherol 
(BDH Merck Ltd.) was prepared by dissolving 
0.0216 g of vitamin E in 5 ml of absolute ethanol. 
Different standards concentrations of α-tocopherol 
(10, 20, 30, 40 and 50 umol/L) were prepared. 
The internal standard, α-tocopheryl acetate, was 
prepared by dissolving 0.0236 g of α-tocopheryl 
acetate in 5 ml of absolute ethanol and then pipetting 
0.75 ml of this into 50 ml of absolute ethanol. The 
final concentration of α-tocopheryl acetate in every 
standard and sample was 150 µmol/L.
Lyphochek 1 and Lyphochek 2 (Bio-Rad 
Laboratories, Hercules, California, USA) were used 
as the low and high precision controls, respectively, 
and treated as plasma samples. A 100 µl of sample 
or standard was added to 100 μl of ethanol together 
with 100 µl of α-tocopheryl acetate. Hexane (200 µl) 
was added and centrifuged at 2,500 g (for 10 mins 
at 4 °C). Then 120 µl of the upper layer (hexane 
extract) was evaporated. A total of 60 μl of the 
mobile phase were added to dissolve the extract, 
and this was immediately loaded for injection into 
the HPLC system.
Analytical HPLC separations were performed 
as previously described in this section. The running 
condition of HPLC was seven mins per sample. The 
flow-rate was 1 ml/min. The injection volume was 
20 μl and the detection wavelength was at 292 nm. 
The retention time was ~4.4 mins for vitamin E and 
~5.3 mins for α-tocopheryl acetate.
A calibration curve was constructed by plotting 
the peak area ratio of vitamin E and α-tocopheryl-
acetate against the vitamin E standard values. The 
slope obtained from the calibration curve was used 
to determine the α-tocopherol concentration in the 
sample by the following calculation:
The deoxyribonucleic acid (DNA) oxida-tive 
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damage was then measured as follows. The alkaline 
single-cell gel electrophoresis assay procedure was 
performed according to the method described by 
Singh et al.17 For slide preparation, 100 µl (0.5%) of 
normal melting agarose at about 121 °C in calcium 
ion- and magnesium ion-free butylphthalate 
plasticised styrene, was immediately covered with 
a cover slip and kept on ice for 5 mins to allow the 
agarose to solidify. Around 10 µl of whole blood was 
suspended in 80 µl (0.5%) of low melting agarose. 
The cell suspension was rapidly pipetted onto the 
first agarose layer and spread using a cover slip, and 
the slides were immersed in a lysis buffer solution 
(2.5 M of NaCl, 100 mM of sodium EDTA, 10 mM 
of trisaminomethane hydrochloride (Tris-HCl) and 
1% of Triton X-100), and 10% dimethyl sulfoxide 
was added just before use at 4 °C for a minimum 
of one hour. The slides were placed in a horizontal 
gel electrophoresis tank and filled with fresh cold 
electrophoresis solution (10 N of sodium hydroxide 
and 200 mM of sodium (in the form of Na2) EDTA) 
and were left in the solution for 20 mins to allow the 
DNA to unwind. Electrophoresis was conducted at 
4 °C for 20 mins. The slides were neutralised with 
a Tris-HCl buffer (pH 7.5) three times for five mins 
and stained with ethidium-bromide (100 µg/ml) for 
10 mins. Slides were examined at x 20 magnification 
using a fluorescence microscope with 100 cells 
per slide analysed using image analysing software 
(Comet Assay Software Project (CaspLab), Version 
1.2.2XCAP™ Image Processing Software (Version 
1.1.1), CaspLabEPIX, Inc., Swietokrzyska Academy, 
Kielce, Poland).
All results were expressed as mean ± standard 
error of mean (SEM). The data were analysed 
using the Statistical Package for the Social Sciences 
(SPSS), Version 20.0 (IBM, Corp., Chicago, Illinois, 
USA), and Microsoft Office Excel 2007 (Microsoft, 
Inc., Redmond, Washington, USA) was used to draw 
the graphs. The Shapiro-Wilk test was used to check 
the normality of the variables. Accordingly, a one-
way analysis of variance (ANOVA) test followed by 
a post hoc least significant difference (LSD) multiple 
comparison test to estimate the significance of 
difference between groups, and the Kruskal-
Wallis one-way ANOVA test was used to analyse 
the data that followed non-normal behaviour of 
distribution patterns, respectively. The difference 
between groups was considered significant when 
P <0.05.
Results
As far as plasma glucose levels are concerned, Figure 
1 shows that the levels of FBG were significantly 
increased (P <0.0001) in the STZ-induced diabetic 
rats compared to the normal group. On the other 
hand, FBG levels were significantly lower in 
the diabetic group (P <0.001), which had been 
supplemented with TRF, in comparison with 
the STZ-induced diabetic rats; however, this 
improvement was not sufficient to have restored 
the blood glucose levels to their normal state. 
As to the MDA erythrocyte membrane, 
the erythrocyte MDA levels were statistically 
significantly higher in the STZ-induced diabetic 
rats (76.69 ± 6.8) compared with the normal rats 
(1.9 ± 0.1; P <0.0001) [Table 1]. On the other 
hand, the diabetic rats treated with TRF showed 
significantly decreased (13.11 ± 0.3; P <0.001) MDA 
levels compared with STZ-induced diabetic rats.
The results for the erythrocyte antioxidants 
status were as follows. In the diabetic group there 
was significantly decreased activity of SOD, GPx 
Table 1: Effects of treatment with tocotrienol-rich fraction on antioxidant status and oxidative stress
Group SOD in U/gHb GPx in U/gHb GSH in µmol/gHb GSSG in nmol/gHb MDA in nmol/gHb
Normal 3673 ± 182 71.6 ± 1.8 8.32 ± 0.66 73.34 ± 2.1 1.9 ± 0.13
Normal with TRF 4028 ± 161† 65.3 ± 4.7† 18.70 ± 0.7* 79.24 ± 1.9† 7.5 ± 0.6
Diabetic 2916 ± 126* 39.3 ± 2.6* 4.91 ± 0.3* 92.75 ± 4.6* 76.6 ± 6.8*
Diabetic with TRF 3364 ± 137† 46.5 ± 3.4 8.84 ± 0.4† 77.76 ± 1.4† 13.1 ± 0.3*†
 
SOD = superoxide dismutase; GPx = glutathione peroxidase; GSH = reduced glutathione; GSSG = oxydised glutathione; MDA = malondialdehyde; 
TRF = tocotrienol-rich fraction. 
Results are expressed as mean ± standard error of mean; *Significantly different as compared to the control group (P <0.05); †Significantly different as 
compared to the diabetic group (P <0.05).
Peak area ratio of the sample
Slope of the calibration curve
μmol
    L( )= Vitamin E concentration in
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and levels of GSH (P values were 0.006, 0.0001 
and 0.001, respectively). On the other hand, levels 
of GSSG were significantly increased (P = 0.002) 
compared with the normal group. However, TRF 
supplementation produced a significant increase 
in SOD activity and levels of GSH, as well as a 
decreased level of GSSG in the diabetic with TRF 
group when compared to the STZ-induced diabetic 
rats group [Table 1 and Figure 1].
As far as the vitamin E erythrocyte membrane 
was concerned, the concentration of vitamin E was 
significantly lower in the diabetic groups (STZ-
induced diabetic rats and diabetic rats with TRF) 
compared with the normal group (0.33 ± 0.03 and 
0.55 ± 0.05 versus 2.07 ± 0.29). P values were 0.01 
and 0.04, respectively. On the other hand, vitamin 
E levels in the normal group supplemented with 
TRF were significantly increased when compared 
to other groups (P = 0.0001) [Figure 2]. 
The levels of DNA damage were significantly 
higher in the STZ-induced diabetic rats compared 
to normal rats [Table 2]. TRF supplementation was 
found to minimise the DNA damage parameters in 
diabetic rats with TRF. Figure 3 shows the normal 
and damaged cells with long tails of DNA migration.
Discussion
This study shows that a daily supplementation of TRF 
(200 mg/Kg) reduced the levels of oxidative stress 
markers in STZ-induced diabetic rats. The results 
of the FBG tests indicated increased plasma glucose 
levels in STZ-induced diabetic rats, which could be 
due to the inhibition of insulin secretion resulting 
from the injection of STZ. Previous studies have 
demonstrated that injections of STZ in experimental 
diabetic rats led to the degeneration of beta cells of 
the islets of Langerhans, thereby increasing FBG 
levels.18 In this study, the supplementation of TRF 
at 200 mg/Kg for four weeks improved blood 
glucose levels. However, the improvement was not 
enough to restore blood glucose levels to a normal 
state.
The mechanism through which tocotrienols 
reduce blood glucose levels in patients and in pre-
clinical animal models was investigated by Fang 
Figure 1: The effect of treatment with tocotrienol-rich 
fraction (TRF) on blood glucose in the experimental 
groups of rats.
a = Significantly different compared to the normal group (P <0.05); 
b = Significantly different from the normal with TRF group (P 
<0.05); c = Significantly different from the diabetic group (P <0.05).
Figure 2: The effect of treatment with tocotrienol-rich 
fraction (TRF) on the concentration of vitamin E in the 
experimental groups of rats.
a = Significantly different from the normal group (P <0.05); b = 
Significantly different from the normal with TRF group (P <0.05).
Table 2: Effect of treatment with tocotrienol-rich 
fraction on the level of deoxyribonucleic acid (DNA) 
damage (determined by tail length, tail moment and 
percentage of tail DNA) of the leukocytes












4.03 ± 0.15 0.0086 ± 0.001 0.084 ± 0.012
Diabetic 
group





45.28 ± 0.75*† 3.93 ± 0.12† 7.93 ± 0.16*†
 
TL = tail length; TM = tail moment; DNA = deoxyribonucleic acid; 
TRF = tocotrienol rich fraction.  
 
Results are expressed as mean ± standard error of mean; *Significantly 
different as compared to the control group (P <0.05); †Significantly 
different as compared to the diabetic group (P <0.05).
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Figure 3: Single-cell gel electrophoresis  assay image of 
the deoxyribonucleic acid (DNA) using rat whole blood 
(10 µl) directly for the assay. Single-cell gel 
electrophoresis image of the DNA in the (A) normal 
group; (B) normal with tocotrienol-rich fraction (TRF) 
group; (C) diabetic group, and (D) diabetic with TRF 
group.
et al.19 They proposed that tocotrienols function 
as peroxisome proliferator-activated receptor 
(PPAR) modulators. PPARs are ligand-regulated 
transcription factors that play essential roles in 
energy metabolism. Synthetic PPARα and PPARγ 
ligands have been used recently in the treatment 
of hyperlipidaemia and diabetes. Both α- and 
γ-tocotrienol activated PPARα, while δ-tocotrienol 
alone activated PPARα, PPARγ and PPARδ in 
reporter-based assays. 
Several studies have shown an increased lipid 
peroxidation in clinical and experimental diabetes.20 
In the first part of this study, we confirmed that 
oxidative stress is enhanced in STZ-induced 
diabetic rats as demonstrated by the significant 
augmentation in diabetic erythrocyte MDA. MDA 
is a late-stage lipid oxidation by-product that can 
be formed non-enzymatically, or is a by-product of 
cyclooxygenase activity.21
Previous studies have reported elevated levels 
of lipid peroxidation products in the erythrocytes, 
plasma and retinas of diabetic patients and 
animals.22 The findings of the present study showed 
elevated levels of lipid peroxidation in erythrocyte 
STZ-induced diabetic rats, and this finding was 
in agreement with the reports documented in the 
literature.22–24 Increased levels of lipid peroxide 
may cause oxidative injury to the erythrocytes and 
cross-linking in the membrane proteins and lipids.25 
Moreover, the levels of MDA were slightly increased 
in the normal group treated with TRF compared 
to the control group, although the difference was 
not statistically significant. This might be related 
to having exposed the rats to stressors during the 
force-feeding of the TRF supplementation.
In this study, four weeks of TRF 
supplementation showed significantly lower 
erythrocyte lipid peroxidation in the diabetic 
with TRF group compared to the STZ-induced 
diabetic group. Moreover, the normalisation of 
lipid peroxides in the STZ-induced diabetic rats 
treated with TRF was in agreement with Sung 
et al., who found that vitamin E inhibited the 
thiobarbituric acid reactive substances in the 
erythrocyte membrane.26 Also, the formation of 
lipid peroxidation products such as MDA was 
prevented by vitamin E treatment. Evidence from the 
present study suggests that TRF supplementation 
may help prevent and protect against free radical 
production in diabetes.
Increased oxidative damage and changes in the 
antioxidant defense system have been reported in 
experimental diabetes and have been associated 
with the development of diabetic complications.27 
Previous studies have shown that the presence of 
oxidative stress in diabetes mellitus, and antioxidant 
enzymes such as SOD, catalase (CAT) and GPx as 
well as molecules such as GSH, vitamins E and C, 
and beta carotene, increase the response of the 
antioxidant defense system to oxidative stress in 
the body.28,29 In the present study, the levels of 
erythrocyte antioxidant enzymes, SOD and GPx, 
were decreased in both the STZ-induced diabetic 
rats and the diabetic with TRF group in comparison 
to the normal group. These findings agree with other 
research showing that the presence of oxidative 
stress in rat erythrocytes was caused by STZ-
induced diabetes.28,30 In this study, supplementation 
with TRF was found to augment the antioxidative 
system and increase the levels of antioxidant 
enzymes, such as SOD, which catalytically converts 
superoxide anion radicals to hydrogen peroxide; 
this was especially remarkable in the diabetic with 
TRF group. While GPx activity was not significantly 
different in the diabetic with TRF group compared 
with the STZ-induced diabetic group, these results 
agree with some previous studies which showed 
that GPx appears to be a relatively stable enzyme;31,32 
thus, it may only be inactivated under conditions of 
severe oxidative stress.33 In addition, other previous 
Tocotrienol-Rich Fraction from Palm Oil Prevents Oxidative Damage in Diabetic Rats
e102 | SQU Medical Journal, February 2014, Volume 14, Issue 1
experimental animal studies have reported that 
high levels of glucose have no effect on GPx activity 
and its gene expression.34
Decreased erythrocyte GSH together with 
significantly increased GSSG was observed in 
STZ-induced diabetic rats when compared with 
the normal rats. These findings are consistent with 
other studies.32 The current study found that the 
supplementation of TRF significantly increased the 
levels of GSH and decreased GSSG in the diabetic 
group treated with TRF, and may indicate that high 
concentrations of TRF can significantly reduce 
the levels of lipid peroxidation and the reduction 
of oxidative agents, thereby increasing levels of 
antioxidant GSH.
The increased production of reactive oxygen 
species (ROS) under diabetic conditions underlines 
the increased amount of oxidatively-damaged DNA 
in different tissues. The presence of ROS may lead 
to increased DNA damage in peripheral blood 
lymphocytes that may be revealed by the single-
cell gel electrophoresis assay. Significant differences 
were detected between the control and STZ-induced 
diabetic rats in terms of the frequency of damaged 
cells. The tail moment (TM) and tail length (TL) 
parameters for DNA damage were significantly 
higher in the STZ-induced diabetic rats than in the 
control rats, which might indicate that these cells are 
handling more oxidative damage on a regular basis. 
Also, clear differences between the STZ-induced 
diabetic rats and diabetic rats with four weeks of 
TRF supplementation were observed on the basis 
of the extent of DNA migration during single-cell 
gel electrophoresis, supporting the hypothesis 
that antioxidants protect cells from DNA damage. 
A previous study showed that antioxidants such 
as vitamin E exhibited a protective effect against 
oxidative DNA damage.35
Conclusion
This study showed that a daily oral supplementation 
of 200 mg/Kg of TRF of palm oil had the beneficial 
effect of reducing levels of oxidative stress markers 
by an inhibition of lipid peroxidation and an 
increase in the levels of antioxidant defense system. 
This was demonstrated through a significant 
increase in the SOD activity, and the GSH levels in 
diabetic rats supplemented with TRF. In contrast, 
GPx activity and vitamin E levels were not 
significantly affected following four weeks of TRF 
supplementation. Furthermore, the antioxidant 
properties of TRF showed some protective effects 
in the reduction of the percentage of damaged DNA 
in the tail. The DNA TL and TM of the leukocyte 
single-cell gel electrophoresis assay were used as 
indicators of oxidative DNA damage. Additionally, 
TRF was also found to have a beneficial effect in 
improving hyperglycaemic status, which resulted 
in a lowering of the plasma glucose levels after four 
weeks of supplementation. This study suggests that 
TRF supplementation plays an important role in 
reducing oxidative stress-induced diabetes mellitus.
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